Risk of postpolypectomy bleeding in patients taking direct oral anticoagulants or clopidogrel

The usage of direct oral anticoagulants (DOACs) to prevent and treat thromboembolic events is gradually increasing. We aimed to evaluate the outcomes of patients taking DOACs after polypectomy. We retrospectively reviewed 131 patients taking DOACs and 270 taking clopidogrel who underwent polypectomy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Gwang-Un, Lee, Sinwon, Choe, Jaewon, Hwang, Sung Wook, Park, Sang Hyoung, Ye, Byong Duk, Byeon, Jeong-Sik, Myung, Seung-Jae, Yang, Suk-Kyun, Yang, Dong-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846554/
https://www.ncbi.nlm.nih.gov/pubmed/33514789
http://dx.doi.org/10.1038/s41598-021-82251-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846554/
https://www.ncbi.nlm.nih.gov/pubmed/33514789
http://dx.doi.org/10.1038/s41598-021-82251-y

Ejemplares similares